Reishi mushroom tested as fatty liver treatment in new study
NCT ID NCT07564947
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether Ganoderma lucidum (a type of mushroom) can improve antioxidant levels and liver health in people with Metabolic Associated Fatty Liver Disease (MAFLD). Forty adults aged 35-49 with early-stage fatty liver will take the mushroom supplement. Researchers will measure changes in liver function, cholesterol, and markers of inflammation and oxidative stress.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FATTY LIVER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The University of Agriculture, Peshawar
Peshawar, Khyber Pakhtunkhwa, 25120, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a gentle yoga practice turn down the Body's pain and inflammation?
- Could a stress hormone be behind the hidden danger of low blood sugar?
- Could a simple blood test flag heart risk in rheumatoid arthritis?
- Grape powder may help aging immune systems — a trial puts it to the test
- Could a mushroom compound turn back the clock on aging?
- Could a daily cocoa drink help keep blood vessels young?